Rephonic
Artwork for MAP - Market Access Podcast

MAP - Market Access Podcast

Dr. Stefan Walzer
Market Access
Artificial Intelligence
Health Economics
Pharmaceutical Industry
Health Technology Assessment
Reimbursement
Oncology
Healthcare
German Healthcare System
Payers
Digital Health Applications
Interoperability
Digital Health
Pharmaceuticals
Pharmacoequity
Pricing Strategies
Virtual Reality
Medtech
Turkey
Systematic Literature Reviews

Market Access (or alternatively reimbursement) in health care is THE key competence in order to be commercially successful with a new drug, medical device or digital health application. However, given the fact that market access is a complex field involving various disciplines and is an ever-changing field, it is difficult to be up to speed with the different evolvements across the world. MAP is T... more

PublishesTwice monthlyEpisodes114Founded5 years ago
Number of ListenersCategories
ScienceBusiness

Listen to this Podcast

Artwork for MAP - Market Access Podcast

Latest Episodes

Tune in to the newest episode of MAP, the Market Access Podcast, where Dr. Stefan Walzer engages in an insightful discussion with Prof. Dr. Thomas Hammerschmidt, a leading expert in Pharmaceutical Management at the Technical University of Applied Sci... more

YouTube

In der deutschsprachigen Spezialfolge des MAP – Market Access Podcast spricht Dr. Stefan Walzer mit Prof. Dr. Afschin Gandjour, Arzt, Gesundheitsökonom und Finanzexperte, über eine der zentralen gesundheitspolitischen Fragen dieser Wochen: Was bedeut... more

YouTube

From Olympic ice to AI-powered leadership: What can Market Access teams learn from elite sports? In the 111+1 anniversary episode of MAP – the Market Access Podcast, Dr. Stefan Walzer interviews Livia Altmann, a former Swiss Olympic ice hockey player... more

YouTube

In the latest episode of MAP – the Market Access Podcast, Dr. Stefan Walzer speaks with Sreeram Ramagopalan, a global expert at the intersection of biotech value, HTA, real‑world evidence and market access. Together they unpack how the UK NICE thresh... more

YouTube

In the latest episode of MAP – the Market Access Podcast, Dr. Stefan Walzer engages with Swiss healthcare strategist Cuno Moser to explore Europe's "innovation paradox" in healthcare. Despite its strengths in research, data quality, and clinical expe... more

YouTube

In the latest episode of the MAP – Market Access Podcast, Dr. Stefan Walzer speaks with pricing and access expert Shrutya Bhalla about how primary research must evolve in an era of AI, policy shocks, and accelerating market complexity. The key takeaw... more

YouTube

In this episode of the MAP – Market Access Podcast, Dr. Stefan Walzer speaks with Hatice Küçük Beton, Executive Director of the G20 Health and Development Partnership, about how to make global health truly investable – and keep it on the political ag... more

YouTube

In the latest Market Access Podcast episode, host Stefan Walzer sits down with Bernard “Bernie” Bichsel – one of Europe’s most experienced voices in medtech regulation and former Head of the Medical Devices Division at Swissmedic – to unpack how regu... more

YouTube

Key Facts

Accepts Guests
Accepts Sponsors
Contact Information
Podcast Host
Number of Listeners
Find out how many people listen to this podcast per episode and each month.

Similar Podcasts

People also subscribe to these shows.

Market Access Matters
Market Access MattersAccess Infinity
Prof G Markets
Prof G MarketsVox Media Podcast Network
Freakonomics Radio
Freakonomics RadioFreakonomics Radio + Stitcher
Pharmaceutical Executive
Pharmaceutical ExecutivePharmaceutical Executive Podcast

Recent Guests

Livia Altmann
Former Swiss Olympic ice hockey player, now focused on human-AI intersection in business
None explicitly stated on episode
Episode: What lessons can Market Access teams learn from an Olympic medalist, Livia Altmann?
Ram Ramagopalan
Expert at the intersection of biotech value creation, market access, health technology assessment, and real-world evidence
Episode: How Are UK NICE and US IRA/MFN Rewriting Global Pharma Pricing, Sreeram Ramagopalan?
Cuno Moser
Swiss health care strategist and digital health expert
Independent consultant / advisor
Episode: How Can Europe Move from Innovation Paradox to Powerhouse, Cuno Moser?
Shrutya Bhalla
Guest and expert in primary research for market access
Episode: Are primary research platforms adapting to payer dynamics, Shrutya Bhalla?
Hatice Küçük Beton
Executive Director for the G20 Health and Development Partnerships
G20 Health and Development Partnerships
Episode: How Can Political Leadership Turn Health into an Economic Priority, Hatice Küçük Benton?
Bernard Bernie Bichsel
Co-CEO and co-owner of ISS in Switzerland; regulatory expert in MedTech
ISS in Switzerland
Episode: Is Europe Still More Attractive Than the US, China, India or MENA for Medtech Investment, Bernard Bichsel?
Helmut Butscher
Market Access Manager and Interim Manager
Episode: From Necessary Tasks to New Insights: How Can AI Act as a Sparring Partner in Market Access, Helmut Butscher?
Omar Ali
Head of Payers at Vipora, pharmacist, specializing in innovative contracting, value-based agreements, and drug pricing negotiation.
Vipora
Episode: Can Innovative Contracting Turn High‑Cost Therapies into Sustainable Deals, Omar Ali?
Zanfina Ademi
Health economist and professor at Monash University, leading a group on Health Economics and Outcome Research.
Monash University
Episode: What Makes Australia’s HTA Approach to Equity and Health Productivity Unique, Zanfina Ademi?

Host

Dr. Stefan Walzer
Host of MAP - Market Access Podcast; health economics, reimbursement, and pricing strategy expert with global launch experience

Top Business Podcasts

Löhr & Pennekamp
Löhr & PennekampFrankfurter Allgemeine Zeitung
OMR Podcast
OMR PodcastPhilipp Westermeyer - OMR
Handelsblatt Morning Briefing - News aus Wirtschaft, Politik und Finanzen
Handelsblatt Morning Briefing - News aus Wirtschaft, Politik und FinanzenFriederike Hofmann, Sven Prange und die Handelsblatt Redaktion, Handelsblatt
Doppelgänger
DoppelgängerPhilipp Glöckler, Philipp Klöckner
Baby got Business
Baby got BusinessAnn-Katrin Schmitz

Talking Points

Recent interactions between the hosts and their guests.

How Can Europe Move from Innovation Paradox to Powerhouse, Cuno Moser?
Q: Where do you see the biggest opportunities for Europe in the next five years?
Translate Europe's structural strengths—trust, regulatory quality, and clinical expertise—into competitive advantages through trust-based health platforms and a co-creative ecosystem, aided by AI for matchmaking and integration.
How Can Europe Move from Innovation Paradox to Powerhouse, Cuno Moser?
Q: From your experience, what would you recommend to move from pilot projects to real execution in Europe, particularly for MedTech and digital health?
Focus on aligning clinical benefits with a fast, integrated reimbursement and revenue model, reduce regulatory fragmentation, improve data interoperability, and develop a marketplace-like matchmaking between startups, investors, and markets to find the best fit for scale.
How Can Europe Move from Innovation Paradox to Powerhouse, Cuno Moser?
Q: Can you explain to the listeners what you mean by Europe being in an innovation paradox in health care?
Europe produces excellent research and medical innovation but struggles to convert pilots into scalable deployment due to systemic issues in incentives, execution, and fragmentation across many reimbursement schemes, which impedes full market adoption.
Is Europe Still More Attractive Than the US, China, India or MENA for Medtech Investment, Bernard Bichsel?
Q: Where does Europe stand in terms of attractiveness for medtech investment compared with the US, China, and India?
Europe remains highly attractive due to innovation, strong academic and industry ecosystems, and SME agility, but investors seek stability and clear regulatory pathways; the US, China, and India also offer opportunities, with the Middle East/North Africa region emerging as a potential fast-growing area.
Is Europe Still More Attractive Than the US, China, India or MENA for Medtech Investment, Bernard Bichsel?
Q: How does the Omnibus package impact smaller versus larger companies?
Omnibus has the potential to ease burden, but its real effect hinges on implementation and political decisions; smaller companies may feel the burden more due to limited resources, whereas larger companies with bigger regulatory teams can adapt more readily.

Audience Metrics

Listeners, social reach, demographics and more for this podcast.

Listeners per Episode
Gender Skew
Location
Interests
Professions
Age Range
Household Income
Social Media Reach

Frequently Asked Questions About MAP - Market Access Podcast

What is MAP - Market Access Podcast about and what kind of topics does it cover?

MAP focuses on market access, reimbursement, and pricing in health care, delivering expert-led conversations with industry leaders and practitioners from pharma, medtech, digital health, and policy. Episodes typically explore how HTA decisions, payer dynamics, and regulatory changes shape launch strategies, pricing, and market access across regions, with recurring emphasis on Europe, the US, and global implications. A standout pattern is the blend of practical, data-driven insights (such as real-world evidence, innovative contracting, and AI-enabled decision support) with strategic guidance for startups and mid-sized companies navigating complex health care systems. The show often features guests who are seasoned economists, regulators, or ... more

Where can I find podcast stats for MAP - Market Access Podcast?

Rephonic provides a wide range of podcast stats for MAP - Market Access Podcast. We scanned the web and collated all of the information that we could find in our comprehensive podcast database. See how many people listen to MAP - Market Access Podcast and access YouTube viewership numbers, download stats, audience demographics, chart rankings, ratings, reviews and more.

How many listeners does MAP - Market Access Podcast get?

Rephonic provides a full set of podcast information for three million podcasts, including the number of listeners. View further listenership figures for MAP - Market Access Podcast, including podcast download numbers and subscriber numbers, so you can make better decisions about which podcasts to sponsor or be a guest on. You will need to upgrade your account to access this premium data.

What are the audience demographics for MAP - Market Access Podcast?

Rephonic provides comprehensive predictive audience data for MAP - Market Access Podcast, including gender skew, age, country, political leaning, income, professions, education level, and interests. You can access these listener demographics by upgrading your account.

How many subscribers and views does MAP - Market Access Podcast have?

To see how many followers or subscribers MAP - Market Access Podcast has on Spotify and other platforms such as Castbox and Podcast Addict, simply upgrade your account. You'll also find viewership figures for their YouTube channel if they have one.

Which podcasts are similar to MAP - Market Access Podcast?

These podcasts share a similar audience with MAP - Market Access Podcast:

1. Market Access Matters
2. Prof G Markets
3. The Readout Loud
4. Freakonomics Radio
5. Pharmaceutical Executive

How many episodes of MAP - Market Access Podcast are there?

MAP - Market Access Podcast launched 5 years ago and published 114 episodes to date. You can find more information about this podcast including rankings, audience demographics and engagement in our podcast database.

How do I contact MAP - Market Access Podcast?

Our systems regularly scour the web to find email addresses and social media links for this podcast. We scanned the web and collated all of the contact information that we could find in our podcast database. But in the unlikely event that you can't find what you're looking for, our concierge service lets you request our research team to source better contacts for you.

Where can I see ratings and reviews for MAP - Market Access Podcast?

Rephonic pulls ratings and reviews for MAP - Market Access Podcast from multiple sources, including Spotify, Apple Podcasts, Castbox, and Podcast Addict.

View all the reviews in one place instead of visiting each platform individually and use this information to decide if a show is worth pitching or not.

How do I access podcast episode transcripts for MAP - Market Access Podcast?

Rephonic provides full transcripts for episodes of MAP - Market Access Podcast. Search within each transcript for your keywords, whether they be topics, brands or people, and figure out if it's worth pitching as a guest or sponsor. You can even set-up alerts to get notified when your keywords are mentioned.

What guests have appeared on MAP - Market Access Podcast?

Recent guests on MAP - Market Access Podcast include:

1. Livia Altmann
2. Ram Ramagopalan
3. Cuno Moser
4. Shrutya Bhalla
5. Hatice Küçük Beton
6. Bernard Bernie Bichsel
7. Helmut Butscher
8. Omar Ali

To view more recent guests and their details, simply upgrade your Rephonic account. You'll also get access to a typical guest profile to help you decide if the show is worth pitching.

Find and pitch the right podcasts

We help savvy brands, marketers and PR professionals to find the right podcasts for any topic or niche. Get the data and contacts you need to pitch podcasts at scale and turn listeners into customers.
Try it free for 7 days